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Dear Editor,
A 49-year-old woman presents with depressive symptoms 
characterized by depressed mood, diminished interest, aggressive 
behavior and recurrent suicide attempt. Symptoms had begun four 
years before, involving irritability, impulsive behavior, fatigue at work 
and persecutory delusions. Two months before, symptoms became 
more intense and she was diagnosed with bipolar disorder. She was 
referred to a psychiatric hospital due to the persistence of symptoms 
after irregular use of haloperidol, risperidone and valproate. There 
was no previous psychiatric history.
During hospitalization, mixed mood symptoms were observed: 
dysphoric mood, psychomotor agitation, suicidal ideation and 
delusions of persecution and ruin. Olanzapine and fluoxetine 
were started and the patient’s mood improved. It was possible to 
distinguish the persistence of sluggish and impoverished thinking, 
spatial disorientation, increased response latency and apathy. 
Neurological examination revealed involuntary choreiform body 
movements imperceptible to the patient, which had started seven 
years before, and vocal tics that had appeared six months earlier. The 
patient had a family history of chorea. Clock drawing test exhibited 
visual spatial impairment; Mini-Mental State Exam revealed general 
cognitive decline (10 points; schooling: 8 years).
Laboratory (CBC, VDRL, HIV test, vitamin B12 levels, ionized 
calcium levels, blood glucose, thyroid, liver and renal function tests) 
was unremarkable. Computed tomography of the brain showed mild 
frontal lobe atrophy associated with dilation of the anterior horns of 
the lateral ventricles and decreased caudate nuclei heads (Figure 1). 
Genetic testing was performed due to suspected Huntington’s disease 
(HD) and yielded 42 cytosine-adenine-guanine (CAG) repeats. 
After discharge, patient maintained mood stability and significant 
reduction of choreiform movements, with the prescription of 
fluoxetine 40 mg/day and olanzapine 10 mg/day. 
HD is a rare inherited neurodegenerative disorder caused by 
the repeated expansion of a CAG trinucleotide, characterized by 
progressive motor, cognitive and psychiatric symptoms. Clinical 
manifestations and disease onset depend on the number of CAG 
repetitions. Symptoms present when there are more than 36 
repetitions. Clinical manifestation is more common between 35 and 
45 years, but can occur at any age. The course is chronic, slow and 
progressive, with an average survival of 10 to 20 years.1,2
Psychiatric manifestations are varied and can occur even in the 
prodromal phase, making diagnosis challenging. Neuropsychiatric 
symptoms occur in 35% to 73% of cases2,3. The most frequent 
manifestations are mood disorders, especially depressive symptoms, 
and an increased risk of suicide.  Episodes of mania or hypomania 
may be present in 10% of cases. Studies show that up to 4.8% of HD 
patients develop bipolar disorder3-5. 
Here, we present the case of a patient diagnosed with HD, 
presenting as mixed state episode in the context of behavioral 
manifestations of a neurodegenerative disease. The patient met DSM 
5 criteria for manic episode with mixed symptoms, due to dysphoric 
mood, psychomotor agitation, aggressive behavior, lack of interest 
and pleasure, delusions of ruin and recurrent thoughts of death. We 
could not find any reports of mixed state episodes in HD. This report 
may help the clinician to consider differential diagnoses regarding 
the onset of psychiatric symptoms associated with neurological 
manifestations.
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Figure 1. Computed Tomography of the brain showing mild frontal lobe 
atrophy associated with dilation of the anterior horns of the lateral ventricles 
and decreased caudate nuclei heads.
